诚达药业
(301201)
| 流通市值：17.62亿 | | | 总市值：31.27亿 |
| 流通股本：8719.38万 | | | 总股本：1.55亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,202,901,471.61 | 1,363,938,914.78 | 1,413,005,628.92 | 1,414,616,247.88 |
| 应收票据及应收账款 | 109,063,174.94 | 124,872,079.24 | 64,892,813.19 | 71,498,659.04 |
| 其中：应收票据 | 411,200 | 250,000 | 2,842,199.33 | 3,901,200 |
| 应收账款 | 108,651,974.94 | 124,622,079.24 | 62,050,613.86 | 67,597,459.04 |
| 应收款项融资 | - | 1,808,850 | - | - |
| 预付款项 | 28,110,197.16 | 2,306,688.74 | 15,936,756.55 | 7,917,489.16 |
| 其他应收款合计 | 521,126.4 | 542,160.21 | 617,824.49 | 84,721.06 |
| 存货 | 115,584,134.66 | 130,470,314.55 | 164,857,644.32 | 166,678,861.24 |
| 其他流动资产 | 11,885,792.73 | 18,927,600.63 | 23,236,705.23 | 25,475,922.48 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,568,715,897.5 | 1,642,866,608.15 | 1,682,547,372.7 | 1,686,271,900.86 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 30,000,000 | 30,000,000 | 30,000,000 | 30,000,000 |
| 投资性房地产 | 47,398,159.2 | 47,683,852.77 | 48,744,500.37 | 29,568,054.91 |
| 固定资产 | 468,031,521.59 | 467,039,987.02 | 339,654,698.22 | 366,802,958.49 |
| 在建工程 | 167,145,518.41 | 179,174,063.28 | 206,776,271.26 | 181,566,966.73 |
| 无形资产 | 33,578,073.75 | 33,849,289.14 | 34,115,814.37 | 34,068,069.97 |
| 长期待摊费用 | 40,527,906.42 | 43,503,289.37 | 9,728,544.63 | 10,790,014.98 |
| 递延所得税资产 | 4,211,431.2 | 4,294,194.6 | 3,423,963.26 | 3,929,095.72 |
| 其他非流动资产 | 44,140,746.42 | 6,913,733.82 | 36,455,492.19 | 26,742,091.05 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 835,033,356.99 | 812,458,410 | 708,899,284.3 | 683,467,251.85 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,403,749,254.49 | 2,455,325,018.15 | 2,391,446,657 | 2,369,739,152.71 |
| 流动负债: | | | | |
| 短期借款 | 2,670,000 | - | - | - |
| 应付票据及应付账款 | 129,731,884.15 | 139,885,259.26 | 103,366,336.16 | 107,109,811.35 |
| 其中：应付票据 | 15,255,860.88 | 31,786,955.46 | 34,965,997.76 | 16,451,842.08 |
| 应付账款 | 114,476,023.27 | 108,098,303.8 | 68,400,338.4 | 90,657,969.27 |
| 预收款项 | 44,303.41 | 283,183.41 | - | - |
| 合同负债 | 10,795,935.09 | 11,870,716.36 | 23,818,580.36 | 4,880,362.14 |
| 应付职工薪酬 | 2,452,878.65 | 5,122,293.91 | 852,729.74 | 768,679.08 |
| 应交税费 | 2,352,466.45 | 8,912,583.6 | 5,136,797.77 | 1,722,672.99 |
| 其他应付款合计 | 3,866,828.96 | 4,051,528.88 | 4,134,119.72 | 32,821,208.9 |
| 应付股利 | - | - | - | 29,008,842 |
| 其他流动负债 | 1,407,045.47 | 1,407,045.47 | - | - |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 153,321,342.18 | 171,532,610.89 | 137,308,563.75 | 147,302,734.46 |
| 非流动负债: | | | | |
| 递延收益 | 3,169,291.33 | 3,430,334.5 | 3,691,377.67 | 3,952,420.84 |
| 递延所得税负债 | 1,355,908.69 | 1,440,113.98 | 1,537,888.01 | 1,622,093.3 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 4,525,200.02 | 4,870,448.48 | 5,229,265.68 | 5,574,514.14 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 157,846,542.2 | 176,403,059.37 | 142,537,829.43 | 152,877,248.6 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 154,713,824 | 154,713,824 | 154,713,824 | 96,696,140 |
| 资本公积 | 1,693,501,553.68 | 1,693,315,283.68 | 1,693,129,013.68 | 1,750,960,427.68 |
| 减:库存股 | 51,931,802.68 | - | - | - |
| 盈余公积 | 55,907,973.27 | 55,907,973.27 | 46,880,147.95 | 46,880,147.95 |
| 未分配利润 | 391,831,207.29 | 373,186,701.29 | 352,418,402.75 | 320,586,154.94 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,244,022,755.56 | 2,277,123,782.24 | 2,247,141,388.38 | 2,215,122,870.57 |
| 少数股东权益 | 1,879,956.73 | 1,798,176.54 | 1,767,439.19 | 1,739,033.54 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,245,902,712.29 | 2,278,921,958.78 | 2,248,908,827.57 | 2,216,861,904.11 |
| 负债和股东权益合计 | 2,403,749,254.49 | 2,455,325,018.15 | 2,391,446,657 | 2,369,739,152.71 |
| 公告日期 | 2024-04-22 | 2024-04-22 | 2023-10-27 | 2023-08-23 |
| 审计意见(境内) | | 标准无保留意见 | | |